Evidence map›Paper›PMID 26175109›Full record

ArticleInternational journal of cancer2016

Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.

Jennifer Drahos, Qian Xiao, Harvey A Risch, Neal D Freedman, Christian C Abnet, Lesley A Anderson, Leslie Bernstein, Linda Brown, Wong-Ho Chow, Marilie D Gammon and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Dose-response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Associations between body mass index and gastroesophageal cancer incidence and mortality: novel insights from a nationwide registry-based cohort study.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Article
  12. Article
  13. Review
  14. Practical Considerations in Diagnosing and Managing Early-Onset GI Cancers.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
    Article
  15. Article
  16. Barrett's esophagus patients are becoming younger: analysis of a large United States dataset.Esophagus : official journal of the Japan Esophageal Society · 2020
    Article
  17. Article
  18. Article
  19. Surveillance for Cancers Associated with Tobacco Use - United States, 2010-2014.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 3 countries.

Jennifer DrahosDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD.
Qian XiaoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD.
Harvey A RischDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
Neal D FreedmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD.
Christian C AbnetDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD.
Lesley A AndersonCentre for Public Health, Queen's University, Belfast, Northern Ireland.
Leslie BernsteinDepartment of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, CA.
Linda BrownRTI International, Rockville, MD.
Wong-Ho ChowDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Marilie D GammonDepartment of Epidemiology, University of North Carolina School, Chapel Hill, NC.
Farin KamangarDepartment of Public Health Analysis, School of Community Health and Policy, Morgan State University, Baltimore, MD.
Linda M LiaoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD.
Liam J MurrayCentre for Public Health, Queen's University, Belfast, Northern Ireland.
Mary H WardDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD.
Weimin YeDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Anna H WuDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA.
Thomas L VaughanProgram in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA.
David C WhitemanPopulation Health, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Michael B CookDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD.
United States Department of Health and Human Services · USDivision of Cancer Epidemiology and GeneticsNational Cancer Institute · USBeckman Research InstituteFred Hutch Cancer Center · USKarolinska Institutet · SEMorgan State University · USQIMR Berghofer Medical Research Institute · AURTI International · USThe University of Texas MD Anderson Cancer Center · USUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · USYale University · US

Funding

Barretts EsophagusZIACP010220 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2011 to 2025
$4.5M
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROLK05CA124911 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 2007 to 2016
$1.6M
BIOSTATISTICAL &ANALYTICAL SUPPORT SERVICESN01CP040501 · CP · WESTAT, INC. · PI LANNOM, LINDA B · 1994 to 1996
–
EPIDEMIOLOGIC STUDY OF ADENOCARCINOMAS OF THE ESOPHAGUSU01CA057949 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 1992 to 1995
–
ADENOCARCINOMAS OF THE ESOPHAGUS AND GASTRIC CARDIAU01CA057983 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GAMMON, MARILIE D · 1992 to 1995
–
EPIDEMIOLOGIC STUDY OF ESOPHAGEAL/GASTRIC ADENOCARCINOMAU01CA057923 · NCI · YALE UNIVERSITY · PI RISCH, HARVEY A · 1992 to 1995
–
SURVEILLANCE EPIDEMIOLOGY AND END RESULTSN01CN005230 · CN · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMAS, DAVID B · 1990 to 1996
–
Intramural NIH HHS Z99 CA999999NCI NIH HHS K05 CA124911NCI NIH HHS N01 CN005230NCI NIH HHS N01-CN05230NCI NIH HHS N01 CP040501NCI NIH HHS N02-CP40501NCI NIH HHS U01 CA057923NCI NIH HHS U01 CA057949NCI NIH HHS U01 CA057983
6 · The paper itself

Abstract

Esophageal (EA) and esophagogastric junction (EGJA) adenocarcinoma have been steadily increasing in frequency in younger people; however, the etiology of these cancers is poorly understood. We therefore investigated associations of body mass index (BMI), cigarette smoking, alcohol consumption, gastroesophageal reflux and use of nonsteroidal anti-inflammatory drugs (NSAIDs) in relation to age-specific risks of EA and EGJA. We pooled individual participant data from eight population-based, case-control studies within the international Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). The analysis included 1,363 EA patients, 1,472 EGJA patients and 5,728 control participants. Multivariable logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for age-specific (<50, 50-59, 60-69, ≥70 years) cancer outcomes, as well as interactions by age. BMI, smoking status and pack-years, recurrent gastroesophageal reflux and frequency of gastroesophageal reflux were positively associated with EA and EGJA in each age group. Early-onset EA (<50 years) had stronger associations with recurrent gastroesophageal reflux (OR = 8.06, 95% CI: 4.52, 14.37; peffect modification  = 0.01) and BMI (ORBMI ≥ 30 vs . <25  = 4.19, 95% CI: 2.23, 7.87; peffect modification  = 0.04), relative to older age groups. In contrast, inverse associations of NSAID use were strongest in the oldest age group (≥70 years), although this apparent difference was not statistically significant. Age-specific associations with EGJA showed similar, but slightly weaker patterns and no statistically significant differences by age were observed. Our study provides evidence that associations between obesity and gastroesophageal reflux are stronger among earlier onset EA cancers.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overAge FactorsAge of OnsetAlcohol DrinkingBarrett EsophagusEsophageal NeoplasmsFemaleGastroesophageal RefluxHumansMaleMiddle AgedOdds RatioRisk Factorsage of onsetcase-control studiesesophageal cancerobesityrisk factors

Identifiers

PMID26175109
PMCPMC4607633
OpenAlexW1533383479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.